Here's why Ohio State and Pitt players will be wearing special shooting shirts and pins for Friday's game and raising funds ...

Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...

The results of CardinALS showed utreloxastat failed to meet its main and secondary goals, including several disease-related ...

Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to ...

Local 5 News is paying tribute to Andy Wyker of Appleton who fought for our country and then fought ALS. His wife Kim ...

Columnist Dagmar Munn has managed the shift to a rollator, scooter, and other assistive devices that help her live a better ...

To partner with the ALS community to drive the discovery of prevention strategies, treatments, and cures for ALS; provide ...

ALS is a progressive neurodegenerative disease — and there is no cure. Brunner, who was running 3 miles a day at the onset of ...

Instead of feeling down, Maya and Maceo focus on what's still possible, pushing the boundaries of what the preconceived ...

But utreloxastat had little effect on ALS in the phase 2 trial. PTC powered the study to show whether twice-daily oral dosing ...